Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | METAP2 | P50579 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.49 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | F2R | P25116 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29276588 | 0.98 | KMT2A (0.60) | KMT2AMEN1USP2MAPTNPC1 | |
| SCHEMBL3441194 | 0.86 | KMT2A (0.68) | KMT2AMEN1USP2MAPTNPC1 | |
| SCHEMBL24118812 | 0.85 | NPC1 (0.62) | KMT2AMEN1USP2MAPTNPC1 | |
| SCHEMBL8469266 | 0.83 | SMO (0.56) | KMT2AMEN1MAPTNPC1RAB9A | |
| SCHEMBL28388092 | 0.83 | MEN1 (0.65) | KMT2AMEN1NPC1RAB9AALDH1A1 | |
| SCHEMBL28017780 | 0.82 | SMO (0.55) | KMT2AMEN1MAPTNPC1RAB9A | |
| SCHEMBL882734 | 0.80 | KMT2A (0.80) | KMT2AMEN1USP2MAPTNPC1 | |
| SCHEMBL30410198 | 0.79 | PRNP (0.46) | KMT2AALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL8052698 | 0.78 | KMT2A (0.69) | KMT2AMEN1USP2MAPTNPC1 | |
| SCHEMBL28158256 | 0.77 | MEN1 (0.60) | KMT2AMEN1MAPTRAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| WO-2024064209-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| WO-2022040799-A1 | ANTIMICROBIAL COMPOSITION | GP TECH INOVASYON TEKNOLOJI VE ARASTIRMA A.S (TR) | 2022-03-03 | — | — | WO | claimed |
| EP-3927334-A1 | NONHORMONAL UNISEX CONTRACEPTIVES | The Regents of The University of California (US) | 2021-12-29 | — | — | EP | claimed |
| US-20210369652-A1 | Nonhormonal Unisex Contraceptives | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-02 | — | — | US | claimed |
| US-11166926-B2 | Compositions and methods for protecting a host from enteric toxigenic pathogens | THE HOSPITAL FOR SICK CHILDREN (CA) | 2021-11-09 | — | — | US | claimed |
| CN-113453673-A | Non-hormone contraceptive for both men and women | 加利福尼亚大学董事会 | 2021-09-28 | — | — | CN | claimed |
| EP-2222319-A2 | TOPICAL DRUGS FOR USE IN ANTIFUNGAL THERAPY | Bayer Consumer Care AG (CH) | 2010-09-01 | — | — | EP | claimed |
| WO-2009062746-A2 | TOPICAL DRUGS FOR USE IN ANTIFUNGAL THERAPY | BAYER CONSUMER CARE AG (CH) | 2009-05-22 | — | — | WO | claimed |
| US-7198800-B1 | Compositions and methods | Ko, Thomas Sai Ying (CN) | 2007-04-03 | — | — | US | claimed |
| EP-1696855-A1 | DERMAL DRUG DELIVERY SYSTEM | Medpharm Limited (GB) | 2006-09-06 | — | — | EP | claimed |
| US-20060130266-A1 | Dermal drug delivery system | MEDPHARM LIMITED (GB) | 2006-06-22 | — | — | US | claimed |
| WO-2005058226-A1 | DERMAL DRUG DELIVERY SYSTEM | MEDPHARM LIMITED (GB) | 2005-06-30 | — | — | WO | claimed |
| JP-2003514875-A | — | — | 2003-04-22 | — | — | JP | claimed |
| EP-1231948-A1 | A PROPELLANT FREE SPRAY-ON SKIN PATCH COMPOSITION FOR IMPROVING WOUND HEALING AND FOR DRUG ADMINISTRATION | Ever Power Holding Inc. (VG) | 2002-08-21 | — | — | EP | claimed |
| WO-2001037890-A1 | A PROPELLANT FREE SPRAY-ON SKIN PATCH COMPOSITION FOR IMPROVING WOUND HEALING AND FOR DRUG ADMINISTRATION | EVER POWER HOLDING INC (VG) | 2001-05-31 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | AHCY, MACO1, ME3 | KMT2A 3975/4885MEN1 2966/4885USP2 2990/4885 |
| US-20210369652-A1 | Nonhormonal Unisex Contraceptives | UQCRC1, UQCRC2, MCU | KMT2A 4070/4885MEN1 2175/4885USP2 1837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.